Access cutting-edge non-hodgkin lymphoma refractory/ relapsed treatment through this clinical trial at a research site in Buffalo. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Buffalo location
Preparing your pre-screening questions…
Access non-hodgkin lymphoma refractory/ relapsed specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related non-hodgkin lymphoma refractory/ relapsed treatment provided free
Check if you qualify for this non-hodgkin lymphoma refractory/ relapsed clinical trial in Buffalo, NY
No-Cost Study Care
Local to Buffalo
Convenient for NY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is a first-in-human (FIH), Phase 1, multicenter, open-label study to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, and evaluate the preliminary anti-tumor activity of LTZ-301 administered as a single agent in adult subjects with relapsed or refractory B-cell non-Hodgkin lymphoma
Sponsor: LTZ Therapeutics, Inc.
Yes, this clinical trial (NCT07121946) has an active research site in Buffalo, NY that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for non-hodgkin lymphoma refractory/ relapsed treatment options in Buffalo, NY, this clinical trial (NCT07121946) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Buffalo research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-hodgkin lymphoma refractory/ relapsed specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all non-hodgkin lymphoma refractory/ relapsed clinical trials near you to find additional studies recruiting in your area.
See all lymphoma clinical trials recruiting in Buffalo — not just this study.
Browse Lymphoma Trials in Buffalo →